625 related articles for article (PubMed ID: 31388135)
21. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.
Stehlik J; Movsesian MA
Expert Opin Investig Drugs; 2006 Jul; 15(7):733-42. PubMed ID: 16787138
[TBL] [Abstract][Full Text] [Related]
22. Small-molecule inhibitors of PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation.
Vijayakrishnan L; Rudra S; Eapen MS; Dastidar S; Ray A
Expert Opin Investig Drugs; 2007 Oct; 16(10):1585-99. PubMed ID: 17922623
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).
Barnette MS
Prog Drug Res; 1999; 53():193-229. PubMed ID: 10616299
[TBL] [Abstract][Full Text] [Related]
24. Isoenzyme-selective cyclic nucleotide phosphodiesterase inhibitors: effects on airways smooth muscle.
Raeburn D; Advenier C
Int J Biochem Cell Biol; 1995 Jan; 27(1):29-37. PubMed ID: 7757880
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
Nicholson CD; Shahid M
Pulm Pharmacol; 1994 Feb; 7(1):1-17. PubMed ID: 8003849
[No Abstract] [Full Text] [Related]
26. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
27. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
28. [Combination therapy with PDE III inhibitor for heart failure].
Watanabe H; Kajimoto K; Kawana M
Nihon Rinsho; 2007 May; 65 Suppl 5():134-9. PubMed ID: 17571377
[No Abstract] [Full Text] [Related]
29. Inhibition of phosphodiesterase 4 in allergic rhinitis.
Baraniuk JN; Tai CF
Curr Allergy Asthma Rep; 2002 May; 2(3):191-2. PubMed ID: 11918859
[No Abstract] [Full Text] [Related]
30. Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies.
Dal Piaz V; Giovannoni MP
Eur J Med Chem; 2000 May; 35(5):463-80. PubMed ID: 10889326
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
Whalen MM; Crews JD
Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
[TBL] [Abstract][Full Text] [Related]
33. Advances in targeting cyclic nucleotide phosphodiesterases.
Maurice DH; Ke H; Ahmad F; Wang Y; Chung J; Manganiello VC
Nat Rev Drug Discov; 2014 Apr; 13(4):290-314. PubMed ID: 24687066
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
Dastidar SG; Rajagopal D; Ray A
Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
Murray KJ; England PJ
Biochem Soc Trans; 1992 May; 20(2):460-4. PubMed ID: 1327922
[No Abstract] [Full Text] [Related]
36. COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1.
Celli B
Chest; 2006 Jan; 129(1):5-6. PubMed ID: 16424403
[No Abstract] [Full Text] [Related]
37. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
38. Chronic obstructive pulmonary disease, inflammation and PDE4 inhibitors.
Halpin DM
Br J Hosp Med (Lond); 2006 Jul; 67(7):370-4. PubMed ID: 16884152
[No Abstract] [Full Text] [Related]
39. Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease.
Spina D
Drugs; 2003; 63(23):2575-94. PubMed ID: 14636078
[TBL] [Abstract][Full Text] [Related]
40. Cilostazol, a phosphodiesterase III inhibitor: future perspectives in atherosclerosis.
da Rosa MP; Baroni GV; Portal VL
Arq Bras Cardiol; 2006 Nov; 87(5):e222-6. PubMed ID: 17396201
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
